These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7597057)

  • 1. Ligand-regulated site-specific recombination.
    Logie C; Stewart AF
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5940-4. PubMed ID: 7597057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists.
    Nichols M; Rientjes JM; Logie C; Stewart AF
    Mol Endocrinol; 1997 Jun; 11(7):950-61. PubMed ID: 9178754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase.
    Metzger D; Clifford J; Chiba H; Chambon P
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6991-5. PubMed ID: 7624356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination.
    Buchholz F; Ringrose L; Angrand PO; Rossi F; Stewart AF
    Nucleic Acids Res; 1996 Nov; 24(21):4256-62. PubMed ID: 8932381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible model for beta-six-mediated site-specific recombination in mammalian cells.
    Servert P; Garcia-Castro J; Díaz V; Lucas D; Gonzalez MA; Martínez-A C; Bernad A
    Nucleic Acids Res; 2006 Jan; 34(1):e1. PubMed ID: 16394020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-specific ecdysone-inducible expression of FLP recombinase in mammalian cells.
    Sawicki JA; Monks B; Morris RJ
    Biotechniques; 1998 Nov; 25(5):868-70, 872-5. PubMed ID: 9821589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible expression based on regulated recombination: a single vector strategy for stable expression in cultured cells.
    Angrand PO; Woodroofe CP; Buchholz F; Stewart AF
    Nucleic Acids Res; 1998 Jul; 26(13):3263-9. PubMed ID: 9628928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteins.
    Logie C; Nichols M; Myles K; Funder JW; Stewart AF
    Mol Endocrinol; 1998 Aug; 12(8):1120-32. PubMed ID: 9717838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
    Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
    Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinase-mediated gene activation and site-specific integration in mammalian cells.
    O'Gorman S; Fox DT; Wahl GM
    Science; 1991 Mar; 251(4999):1351-5. PubMed ID: 1900642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cre recombinase activity using modified androgen receptor ligand binding domains: a sensitive assay for ligand-receptor interactions.
    Kaczmarczyk SJ; Green JE
    Nucleic Acids Res; 2003 Aug; 31(15):e86. PubMed ID: 12888538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prokaryotic expression of DNA recombinase FLP and its purification with enzymatic activity].
    Gai Y; Wang WQ; Lu H; Jiang XN
    Sheng Wu Gong Cheng Xue Bao; 2007 Jul; 23(4):724-9. PubMed ID: 17822052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chimeric Cre recombinase inducible by synthetic,but not by natural ligands of the glucocorticoid receptor.
    Brocard J; Feil R; Chambon P; Metzger D
    Nucleic Acids Res; 1998 Sep; 26(17):4086-90. PubMed ID: 9705523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-activated Flpe for temporally regulated gene modifications.
    Hunter NL; Awatramani RB; Farley FW; Dymecki SM
    Genesis; 2005 Mar; 41(3):99-109. PubMed ID: 15729687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinase.
    Maetzig T; Kuehle J; Schwarzer A; Turan S; Rothe M; Chaturvedi A; Morgan M; Ha TC; Heuser M; Hammerschmidt W; Baum C; Schambach A
    Biomaterials; 2014 May; 35(14):4345-56. PubMed ID: 24529624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-reciprocal crossover mediated by FLP-recombinase: a concept and an assay.
    Seibler J; Bode J
    Biochemistry; 1997 Feb; 36(7):1740-7. PubMed ID: 9048557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target-specific variants of Flp recombinase mediate genome engineering reactions in mammalian cells.
    Shah R; Li F; Voziyanova E; Voziyanov Y
    FEBS J; 2015 Sep; 282(17):3323-33. PubMed ID: 26077105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cre::FLP fusion protein recombines FRT or loxP sites in transgenic maize plants.
    Djukanovic V; Lenderts B; Bidney D; Lyznik LA
    Plant Biotechnol J; 2008 Oct; 6(8):770-81. PubMed ID: 18627532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible site-specific recombination in the brain.
    Kellendonk C; Tronche F; Casanova E; Anlag K; Opherk C; Schütz G
    J Mol Biol; 1999 Jan; 285(1):175-82. PubMed ID: 9878397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Inducible Molecular Switches Based on All-in-One Lentiviral Vectors Equipped with Drug Controlled FLP Recombinase.
    Maetzig T; Schambach A
    Methods Mol Biol; 2016; 1448():23-39. PubMed ID: 27317170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.